Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes

ανά Zhao, Na, Liu, Chia-Chen, Van Ingelgom, Alexandra J., Martens, Yuka A., Linares, Cynthia, Knight, Joshua A., Painter, Meghan M., Sullivan, Patrick M., Bu, Guojun
Τόπος έκδοσης Neuron (2017)

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

ανά Qie, Yaqing, Yuan, Hengfeng, von Roemeling, Christina A., Chen, Yuanxin, Liu, Xiujie, Shih, Kevin D., Knight, Joshua A., Tun, Han W., Wharen, Robert E., Jiang, Wen, Kim, Betty Y.S.
Τόπος έκδοσης Sci Rep (2016)

Corrigendum: Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes

ανά Qie, Yaqing, Yuan, Hengfeng, von Roemeling, Christina A., Chen, Yuanxin, Liu, Xiujie, Shih, Kevin D., Knight, Joshua A., Tun, Han W., Wharen, Robert E., Jiang, Wen, Kim, Betty Y. S.
Τόπος έκδοσης Sci Rep (2016)

APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid

ανά Zhao, Na, Attrebi, Olivia N., Ren, Yingxue, Qiao, Wenhui, Sonustun, Berkiye, Martens, Yuka A., Meneses, Axel D., Li, Fuyao, Shue, Francis, Zheng, Jiaying, Van Ingelgom, Alexandra J., Davis, Mary D., Kurti, Aishe, Knight, Joshua A., Linares, Cynthia, Chen, Yixing, Delenclos, Marion, Liu, Chia-Chen, Fryer, John D., Asmann, Yan W., McLean, Pamela J., Dickson, Dennis W., Ross, Owen A., Bu, Guojun
Τόπος έκδοσης Sci Transl Med (2020)

APOE ε2 is associated with increased tau pathology in primary tauopathy

ανά Zhao, Na, Liu, Chia-Chen, Van Ingelgom, Alexandra J., Linares, Cynthia, Kurti, Aishe, Knight, Joshua A., Heckman, Michael G., Diehl, Nancy N., Shinohara, Mitsuru, Martens, Yuka A., Attrebi, Olivia N., Petrucelli, Leonard, Fryer, John D., Wszolek, Zbigniew K., Graff-Radford, Neill R., Caselli, Richard J., Sanchez-Contreras, Monica Y., Rademakers, Rosa, Murray, Melissa E., Koga, Shunsuke, Dickson, Dennis W., Ross, Owen A., Bu, Guojun
Τόπος έκδοσης Nat Commun (2018)